The AIDS Clinical Trials Group (ACTG), the largest global HIV
WHO urges to address the high price and limited production of antibody combination for COVID-19
The World Health Organization (WHO) welcomes the addition of another
Adenovirus-based nanoparticle vaccine elicits potent SARS-CoV-2 neutralizing antibody response
The coronavirus disease 2019 (COVID-19) pandemic has had devastating effects
Single protein is a key player in two very common forms of dementia, study reveals
Dementia has many faces, and because of the wide range
New hope for antibody to treat muscular dystrophy
Northwestern Medicine scientists have developed an antibody that they believe
Antibody cocktail neutralizes SARS-CoV-2 and has projected protection up to 12 months
Vaccine research continues to provide safe, effective, and durable protection
Study shows difference in antibody levels in response to SARS-CoV-2 infection and type of vaccination
The rapid spread of the severe acute respiratory syndrome coronavirus
RBD and NTD antibody cocktail could prevent the emergence of SARS-CoV-2 escape mutants
Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), the agent of the
SpaceX study profiles evolution of antibody response during COVID-19 infection
New research published on the preprint server bioRxiv* suggests S2-specific
Antibody response following SARS-CoV-2 mRNA vaccine is greater than natural infection
Researchers in the United States have provided the first evidence